Dermatology · Autoimmune Bullous Diseases
The facts most likely to be tested
Bullous pemphigoid is an autoimmune subepidermal blistering disease caused by IgG autoantibodies against hemidesmosomes at the dermal-epidermal junction.
The classic clinical presentation involves tense bullae on an erythematous base, most commonly affecting the flexural surfaces and lower abdomen in elderly patients.
A negative Nikolsky sign is a hallmark clinical feature that helps distinguish bullous pemphigoid from pemphigus vulgaris.
Oral mucosal involvement is rare and significantly less common than in pemphigus vulgaris.
The gold standard for diagnosis is direct immunofluorescence (DIF) showing linear IgG and C3 deposition along the dermal-epidermal junction.
Histopathology reveals a subepidermal split with a prominent eosinophilic infiltrate.
First-line treatment for localized or generalized disease is high-potency topical corticosteroids such as clobetasol.
Vignette unlocked
An 82-year-old male presents to the clinic with a two-week history of a pruritic rash. Physical examination reveals multiple tense bullae distributed across his axillae, groin, and periumbilical region. There is no evidence of oral mucosal erosions. Gentle lateral pressure on the perilesional skin does not cause the epidermis to slough, indicating a negative Nikolsky sign. The patient has no significant past medical history and is not currently taking any new medications.
What is the most likely diagnosis?
Bullous pemphigoid
The presence of tense bullae in an elderly patient with a negative Nikolsky sign and lack of mucosal involvement is classic for bullous pemphigoid, which is confirmed by the presence of IgG and C3 at the dermal-epidermal junction.
Full handout
High yield triage
Etiology / Epidemiology
Autoimmune disorder primarily affecting elderly patients >60 years old.
Clinical Manifestations
Tense, pruritic bullae on an erythematous base; Nikolsky sign negative.
Diagnosis
Direct immunofluorescence showing linear IgG and C3 at the dermal-epidermal junction.
Treatment
High-potency topical corticosteroids (e.g., clobetasol) are the first-line therapy.
Prognosis
Chronic condition with relapsing-remitting course; mortality linked to secondary infection.
Full handout
Epidemiology & Etiology
Occurs predominantly in the elderly population. Often idiopathic, but can be triggered by medications including diuretics, NSAIDs, and gliptins.
Pertinent Anatomy
Targets the hemidesmosomes located at the basement membrane zone. This structural failure leads to the separation of the epidermis from the dermis.
Pathophysiology
Autoantibodies (IgG) target BP180 and BP230 antigens. This triggers a complement-mediated inflammatory cascade, resulting in subepidermal blister formation.
Clinical Manifestations
Presents with tense bullae that do not rupture easily. The Nikolsky sign is characteristically negative, distinguishing it from pemphigus vulgaris. Secondary infection is a major risk due to extensive skin denudation.
Diagnosis
The gold standard is direct immunofluorescence (DIF) of perilesional skin. Histopathology shows a subepidermal blister with eosinophilic infiltration.
Treatment
High-potency topical corticosteroids are the standard of care for localized or generalized disease. For severe cases, systemic corticosteroids or steroid-sparing agents like methotrexate are used. Avoid systemic steroids in patients with severe comorbidities if possible.
Prognosis
Generally a self-limiting disease but requires long-term management. Mortality is often associated with the frailty of the elderly and complications from chronic immunosuppression.
Differential Diagnosis
Pemphigus vulgaris: flaccid bullae and Nikolsky sign positive
Dermatitis herpetiformis: associated with celiac disease and grouped vesicles
Erythema multiforme: target lesions and mucosal involvement
Epidermolysis bullosa acquisita: trauma-induced blistering
Linear IgA bullous dermatosis: string of pearls sign